Medical Nutrition Therapy Act of 2025

The Medical Nutrition Therapy Act of 2025 (HR6199) was introduced in the House on November 20, 2025, and has been referred to the Committees on Energy and Commerce and Ways and Means. This bill seeks to amend title XVIII of the Social Security Act to expand Medicare coverage for medical nutrition therapy services beyond the current scope of diabetes and kidney disease to include conditions such as obesity, eating disorders, cancer, and HIV/AIDS. It also broadens the types of healthcare professionals, including physician assistants, nurse practitioners, and clinical nurse specialists, who can refer patients for these services. While HR6199 does not appropriate specific funds, its passage would significantly alter the payment landscape for nutrition services under Medicare. By expanding coverage, it would create new revenue streams for healthcare providers and health systems that offer medical nutrition therapy. This would also increase demand for diagnostic testing related to these chronic conditions and for nutrition-focused products and services offered by retailers. Companies like UnitedHealth Group ($UNH) would see increased claims processing and potential expansion opportunities for their Optum health services. CVS Health ($CVS) could leverage its MinuteClinic and pharmacy network to provide these expanded services. Major retailers such as Walmart ($WMT), Kroger ($KR), and Dollar General ($DG) could benefit from increased consumer demand for healthy food options and nutrition-related products. Labcorp ($LH) would likely experience higher demand for diagnostic testing associated with the newly covered chronic conditions. The bill's early stage means its ultimate passage and timeline are uncertain, but the introduction of a companion bill (S3934) in the Senate indicates bipartisan interest. There are no direct presidential actions provided that amplify or conflict with this specific bill. The Executive Order on Accelerating Medical Treatments for Serious Mental Illness focuses on psychedelic-based therapies and does not directly relate to medical nutrition therapy coverage under Medicare.